Organ Transplantation Market Research Report, By Type Of Organ (Heart, Kidney, Others), By Products (Organ Preservation Solutions, Transplant Diagnostics, Tissue Products), By Type Of Transplant (Autograft, Allograft And Others), By Treatment (Analgesic, Immunosuppressant And Other), By End Users (Hospitals, Transplant Centers And Other)- Forecast Till 2027
ID: MRFR/Pharma/0410-HCR | February 2021 | Region: Global | 80 pages
Organ Transplantation Market Overview:
Organ transplantation is a medical procedure in which an organ is taken from one body and is being transferred to another body, to fill up or replace the missing or damaged organ respectively. But before this dynamic procedure starts the consent of the family or the patient himself is very important. Without consent, organ harvesting is an illegal and heinous crime. This procedure of organ transplantation is mostly carried out with patients with a dead brain whose other organs are healthy and can be used to save another person’s life. It is mandatory thing that this organ transplantation is to be done right after the death of the patient until a couple of hours. This procedure is performed most of the time to treat organ failures in the lungs, kidneys, liver, and many more.
The Organ transplantation market share is expected to grow compound annual growth rate of 9.8% during the period of forecast.
COVID-19 Analysis of Organ transplantation Market
The coronavirus pandemic has given a very hard time to most of the manufacturing, developing, production, and logistic units of the organ transplantation market. The organ transplantation market has been affected severely. Total transportation procedures went down to 50% during the Covid-19 pandemic. Also, the transplantation procedures which were getting performed during the pandemic were performed after four weeks of infection. The number of transplantation procedures was also limited as it was said in the recent researches that the post-transplantation patients were open to higher risks of getting infected by Covid-19.
Market Dynamics
Drivers
Every 1 person out of 1000 is suffering from the chronic disease today which most of the time results in organ failure and the person affected is always awaits for an organ donor to come and provide him for filling up his deficiency. This factor is driving the organ transplantation industry growth to a large extent. Other factors like overconsumption of alcohol and unhealthy diet being prevalent among the population are leading to people getting affected with renal diseases that also lead to organ failures. So this is another factor responsible for growth of organ transplantation market.
Restraints
The first thing the transplantation of a human organ is a very complex procedure and requires very fine skills to perform it and there is a very less number of surgeons present in this field who can perform these types of procedures so the cost of this transplantation procedure is very high priced. This factor may hinder the organ transplantation market growth to a great extent. Secondly, the number of organ donor are very less in number as compared to the people who need such organs. And day by day increasing incidents of organ failure is yet another major factor that may hamper the growth of organ transplantation market.
Technology Analysis
Well, the transplantation of a human organ is itself a new-fangled invention in the field of medical science. The kidney is the most transplanted organ followed by the liver and eyes. But the need for organ donors is much more than the number of people who donate organs. According to the national kidney foundation, every month, almost 3000 new patients are added to the kidney waiting list. According to research reports every day, about 21 people die while waiting for organs and more than 1 lakh 20 thousand men, women, and children look for life-saving organ transplants. Every medical science college and university is indulged in researching new ways of preserving the organs during their transportation and how to efficiently reduce the complex procedure of transplantations into a simple one without affecting patient’s health.
Figure 1- Global Organ Transplantation Market, by type of organ
Source- Annual reports, Press release, White paper, Company Presentation ,Council of Europe, MRFR Analysis
Study Objectives
- To consider the viewpoint of various industry experts and leaders and predict compound annual growth rate and organ transplantation market growth rate by the end of the global forecast in 2023.
- To highlight a competitive Organ transplantation market outlook and examine the yield models of key market players, worldwide.
- To observe the various market dynamics like trends, drivers, and restraints that are most probable to play a role in helping the market and its different segments growing in the domestic as well as international organ transplantation market .
Organ transplantation Market Segment Overview
Organ transplantation's market share is anticipated to witness significant growth owing to the performance of different market segments. Among these segments, the organ preservation solutions and transplant diagnostics segment will be the fastest-growing and also contribute towards this market more than any other segment. The increasing incidents of organ failure due to various deadly diseases and their treatment is one of the factors responsible for the growth of organ transplantation market. Also while transporting the organ from the donor's place to receivers it is very important to preserve them and the need for such technologies is driving more inventions in this sector. For an amplifying use the organ transplantation market is segmented into the following on different bases:
- Based on the type of organ, it has the heart, kidney, liver, lungs, and others.
- Based on products, it has organ preservation solutions, transplant diagnostics, tissue products, and others.
- Based on the type of transplant, it has autograft, allograft and ALLOTRANSPLANTATION, XENO graft and xenotransplantation, and others.
- Based on end-users, it has hospitals, transplant centers, and others.
- Based on treatment, it has analgesic, immunosuppressant, and others. An immunosuppressant is further divided into CALCINEURIN inhibitors, mTOR inhibitor, anti-proliferative agents, steroids and other. CALCINEURIN inhibitors are further divided into TACROLIMUS and cyclosporine. And MTOR is further divided into SIROLIMUS and EVEROLIMUS.
Organ transplantation Market Regional Analysis
The Organ transplantation industry movements are remarkably working in 5 major regions of the world that is North America, Asia Pacific, Africa, South America, and the Middle East. Among all these regions, the North American region will dominate the market and the reason attributed to it is the fully developed health care sector and massive expenditure on healthcare. Also the rising incidences of organ failure and increasing technological advancements in the healthcare sector of this region. Europe will be the second-largest industry followed by the Asia Pacific region. As a large population is suffering from chronic disease and rapidly developing economies are the major factors responsible for the growth of organ transplantation market in the Asia Pacific region.
Organ transplantation Market Competitive Landscape
To get a detailed and profound idea about the organ transplantation market insights, it is very important to create a competitive environment amongst the different key players at different market locations all around the country. . All the market players are competing with each other globally in the international markets by implementing various types of strategies such as product launches and upgradations, mergers and acquisitions, partnerships, etc. The prime players of the organ transplantation market include:-
- Novartis International AG (Switzerland)
- Terumo Medical Corporation (US)
- Transonic (US)
- Hoffmann-La Roche Ltd. (Switzerland)
- ASTELLAS PHARMA, Inc. (Japan)
- Preservation Solutions, Inc. (US)
- Organ OX Limited (UK)
- Bio-Med PVT. Ltd. (US)
- Transplant Biomedical (UK)
- Trans Medic, Inc. (US)
- Accord Healthcare GmbH (Spain)
- SANOFI (France)
- Pfizer, Inc. (US)
- VELOXIS Pharmaceuticals A/S (Denmark)
- GlaxoSmithKline Plc. (UK)
RECENT DEVELOPMENTS
- In March 2019, the first-ever kidney transplantation was performed by a living donor going through HIV CONDITION was performed by surgeons of Baltimore. This surgery was a landmark in medical science for patients who need a new organ as they are affected with immunodeficiency syndrome (AIDS virus).
- In April 2019, a new organ transport system that will be much safer and efficient than the traditional measures was developed by a Boston-based tech company named PARAGONIX technology. The aim of developing this new system was to boost the capability of controlling the temperature of organs and extend the feasible standard window of 4 hours.
- In September 2016, INSTRATEK, a prime manufacturer of minimally intrusive soft tissue recession instruments was acquired by STRYKER for ankle, foot, and upper extremity procedures.
- In November 2020, the launch of generic immunosuppressant drug TACROLIMUS was announced by LUPIN in the US market which indicated the prevention of organ rejection in the allogeneic liver, kidney, and heart transplant.
- In September 2015, a new ORTHOBIOLOGIC product named ARTHROFLEX ACELLULAR Dermal Matrix was launched by ARTHREX Inc. which is intended to be used in capsular reconstruction
Intended Audience
- Pharmaceutical companies
- Research and Development (R&D) companies
- Independent research laboratories
- Market research and consulting service providers
- Medical research laboratories
- Academic medical institutes and universities
Report Overview
The Organ transplantation market report presents a shift analysis that includes market drivers, opportunities, and restraints that are available in the global market. The report discusses the impact of covid-19 on the key players of the Organ transplantation industry. The report also tells about the market segmentation on a different basis and how a competitive environment is developed among the key players around the globe. At last, the report presents some recent developments in the field of the Organ transplantation market.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 2018-2023: 9.8% |
| Base Year | 2019 |
| Forecast Period | 2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Organ, Into Heart, Kidney, Liver, Lungs, And Other |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors |
|
| Key Market Opportunities | Rapidly developing economies |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The Organ Transplantation Market is expected to exhibit a strong 9.8% CAGR over the Forecast Period from 2017 to 2023.
The Growing Prevalence of Chronic Diseases That Lead to Organ Failure Is the Major Driver for The Global Organ Transplantation Market.
The High Cost of Organ Transportation and The Dearth of Suitable Donors Are the Major Restraint On The Global Organ Transplantation Market.
The Americas dominate the Global Organ Transplantation Market.
Leading Players In The Organ Transplantation Market Include GSK, Terumo, And Novartis, Among Others.
TABLE OF CONTENTS
1 Organ Transplantation Market Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2 Organ Transplantation Market Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Organ Transplantation Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Organ Transplantation Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Organ Transplantation Market, By Type of Organ
5.1 Heart
5.2 Kidney
5.3. Liver
5.4 Lungs
5.5 Other
6. Global Organ Transplantation Market, By Products
6.1 Organ Preservation Solutions
6.2 Transplant Diagnostics
6.3 Tissue Products
6.4 Other
7. Global Organ Transplantation Market, By Type of Transplant
7.1 Autograft
7.2 Allograft and Allotransplantation
7.3 Xenograft and Xenotransplantation
7.4 Other
8. Global Organ Transplantation Market, By Treatment
8.1 Analgesic
8.2 Immunosuppressant
8.2.1 Alcineurin Inhibitors
8.2.1.1 Tacrolimus
8.2.1.2 Cyclosporine
8.2.2 Mtor Inhibitor
8.2.2.1 Sirolimus
8.2.2.2 Everolimus
8.2.3 Antiproliferative Agents
8.2.4 Steroids
8.2.5 Other
8.3 Other
9. Global Organ Transplantation Market, By End User
9.1 Hospitals
9.2 Transplant Centers
9.3 Other
10. Global Organ Transplantation Market, By Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.3 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic Of Korea
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of Middle East & Africa
11. Organ Transplantation MarketCompetitive Landscape
11.1 Major Strategies Adopted By Market Players
11.1.1 Strategic Partnership
11.1.2 Merger & Acquisition
12 Organ Transplantation Market Company Profile
12.1 NOVARTIS INTERNATIONAL AG
12.1.1 Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 Key Developments
12.2 TERUMO
12.2.1 Overview
12.2.2 Product Overview
12.2.3 Financials
12.2.4 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD
12.3.1 Overview
12.3.2 Product Overview
12.3.3 Financials
12.3.4 Key Development
12.4 ASTELLAS PHARMA, INC
12.4.1 Overview
12.4.2 Product Overview
12.4.3 Financials
12.4.4 Key Developments
12.5 PRESERVATION SOLUTIONS, INC
12.5.1 Overview
12.5.2 Product Overview
12.5.3 Financials
12.5.4 Key Developments
12.6 TRANSMEDIC
12.6.1 Overview
12.6.2 Product Overview
12.6.3 Financials
12.6.4 Key Developments
12.7 PFIZER, INC
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.8 SANOFI
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Development
12.9 VELOXIS PHARMACEUTICALS A/S
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.4 Key Development
12.10 Others
13 Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Organ Transplant Industry
14 Appendix
LIST OF TABLES
Table 1 Organ Transplantation Industry Synopsis, 2020-2027
Table 2 Global Organ Transplantation Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Global Organ Transplantation Market by Region, 2020-2027, (USD Million)
Table 4 Global Organ Transplantation Market by Type of Organ, 2020-2027, (USD Million)
Table 5 Global Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 6 Global Organ Transplantation Market by Type of Transplant, 2020-2027, (USD Million)
Table 7 Global Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 8 Global Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 9 Americas Organ Transplantation Market by Type of Organ, 2020-2027, (USD Million)
Table 10 Americas Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 11 Americas Organ Transplantation Market by Type of Transplant, 2020-2027, (USD Million)
Table 12 Americas Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 13 Americas Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 14 North America Organ Transplantation Market by Type of Organ, 2020-2027, (USD Million)
Table 15 North America Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 16 North America Organ Transplantation Market by Type of Transplant, 2020-2027, (USD Million)
Table 17 North America Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 18 North America Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 19 U.S. Market by Type of Organ, 2020-2027, (USD Million)
Table 20 U.S. Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 21 U.S. Market by Type of Transplant, 2020-2027, (USD Million)
Table 22 U.S. Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 23 U.S Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 24 Canada Market by Type of Organ, 2020-2027, (USD Million)
Table 25 Canada Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 26 Canada Market by Type of Transplant, 2020-2027, (USD Million)
Table 27 Canada Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 28 Canada Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 29 South America Organ Transplantation Market by Type of Organ, 2020-2027, (USD Million)
Table 30 South America Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 31 South America Market by Type of Transplant, 2020-2027, (USD Million)
Table 32 South America Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 33 South America Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 34 Europe Organ Transplantation Market by Type of Organ, 2020-2027, (USD Million)
Table 35 Europe Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 36 Europe Organ Transplantation Marketby Type of Transplant, 2020-2027, (USD Million)
Table 37 Europe Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 38 Europe Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 39 Western Europe Organ Transplantation Market by Type of Organ, 2020-2027, (USD Million)
Table 40 Western Europe Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 41 Western Europe Organ Transplantation Market by Type of Transplant, 2020-2027, (USD Million)
Table 42 Western Europe Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 43 Western Europe Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 44 Eastern Europe Organ Transplantation Market by Type of Organ, 2020-2027, (USD Million)
Table 45 Eastern Europe Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 46 Eastern Europe Organ Transplantation Market by Type of Transplant, 2020-2027, (USD Million)
Table 47 Eastern Europe Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 48 Eastern Europe Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 49 Asia Pacific Organ Transplantation Market by Type of Organ, 2020-2027, (USD Million)
Table 50 Asia Pacific Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 51 Asia Pacific Organ Transplantation Market by Type of Transplant, 2020-2027, (USD Million)
Table 52 Asia Pacific Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 53 Asia Pacific Organ Transplantation Market by End Users, 2020-2027, (USD Million)
Table 54 Middle East & Africa Organ Transplantation Market by Type of Organ, 2020-2027, (USD Million)
Table 55 Middle East & Africa Organ Transplantation Market by Product, 2020-2027, (USD Million)
Table 56 Middle East & Africa Organ Transplantation Market by Type of Transplant, 2020-2027, (USD Million)
Table 57 Middle East & Africa Organ Transplantation Market by Treatment, 2020-2027, (USD Million)
Table 58 Middle East & Africa Organ Transplantation Market by End Users, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Organ Transplantation Market
Figure 3 Segmentation Market Dynamics for Global Organ Transplantation Market
Figure 4 Global Organ Transplantation market Share, by Type of Organ, 2020-2027 (USD Million)
Figure 5 Global Organ Transplantation market Share, by Product, 2020-2027 (USD Million)
Figure 4 Global Organ Transplantation market Share, by Type of Transplant, 2020-2027 (USD Million)
Figure 5 Global Organ Transplantation market Share, by Treatment, 2020-2027 (USD Million)
Figure 6 Global Organ Transplantation Market Share, by End Users, 2020-2027 (USD Million)
Figure 7 Global Organ Transplantation Market Share, by Region, 2020 (%)
Figure 8 America Organ Transplantation Market Share, by Region, 2020 (%)
Figure 9 North America Organ Transplantation Market Share, by Country, 2020 (%)
Figure 10 Europe Organ Transplantation Market Share, by Country, 2020 (%)
Figure 11 Asia Pacific Organ Transplantation Market Share, by Country, 2020 (%)
Figure 12 Middle East & Africa Organ Transplantation Market Share, by Country, 2020 (%)
Figure 13 Global Organ Transplantation Market: Company Share Analysis, 2020 (%)
Figure 14 Novartis International AG: Key Financials ofOrgan Transplantation Market
Figure 15 Novartis International AG: Segmental Revenue ofOrgan Transplantation Market
Figure 16 Novartis International AG: Geographical Revenue ofOrgan Transplantation Market
Figure 17 F. HOFFMANN-LA ROCHE LTD: Key Financials
Figure 18 F. HOFFMANN-LA ROCHE LTD: Segmental Revenue
Figure 19 F. HOFFMANN-LA ROCHE LTD: Geographical Revenue
Figure 20 Pfizer Inc: Key Financials
Figure 21 Pfizer Inc: Segmental Revenue
Figure 22 Pfizer Inc: Geographical Revenue
Figure 23 SANOFI: Key Financials
Figure 24 SANOFI: Segmental Revenue
Figure 25 SANOFI: Geographical Revenue
Figure 26 Astellas Pharma, Inc: Key Financials
Figure 27 Astellas Pharma, Inc: Segmental Revenue
Figure 28 Astellas Pharma, Inc: Geographical Revenue